KS6B1_HUMAN - dbPTM
KS6B1_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID KS6B1_HUMAN
UniProt AC P23443
Protein Name Ribosomal protein S6 kinase beta-1
Gene Name RPS6KB1
Organism Homo sapiens (Human).
Sequence Length 525
Subcellular Localization Cell junction, synapse, synaptosome. Mitochondrion outer membrane. Mitochondrion. Colocalizes with URI1 at mitochondrion.
Isoform Alpha I: Nucleus. Cytoplasm.
Isoform Alpha II: Cytoplasm.
Protein Description Serine/threonine-protein kinase that acts downstream of mTOR signaling in response to growth factors and nutrients to promote cell proliferation, cell growth and cell cycle progression. Regulates protein synthesis through phosphorylation of EIF4B, RPS6 and EEF2K, and contributes to cell survival by repressing the pro-apoptotic function of BAD. Under conditions of nutrient depletion, the inactive form associates with the EIF3 translation initiation complex. Upon mitogenic stimulation, phosphorylation by the mammalian target of rapamycin complex 1 (mTORC1) leads to dissociation from the EIF3 complex and activation. The active form then phosphorylates and activates several substrates in the pre-initiation complex, including the EIF2B complex and the cap-binding complex component EIF4B. Also controls translation initiation by phosphorylating a negative regulator of EIF4A, PDCD4, targeting it for ubiquitination and subsequent proteolysis. Promotes initiation of the pioneer round of protein synthesis by phosphorylating POLDIP3/SKAR. In response to IGF1, activates translation elongation by phosphorylating EEF2 kinase (EEF2K), which leads to its inhibition and thus activation of EEF2. Also plays a role in feedback regulation of mTORC2 by mTORC1 by phosphorylating RICTOR, resulting in the inhibition of mTORC2 and AKT1 signaling. Mediates cell survival by phosphorylating the pro-apoptotic protein BAD and suppressing its pro-apoptotic function. Phosphorylates mitochondrial URI1 leading to dissociation of a URI1-PPP1CC complex. The free mitochondrial PPP1CC can then dephosphorylate RPS6KB1 at Thr-412, which is proposed to be a negative feedback mechanism for the RPS6KB1 anti-apoptotic function. Mediates TNF-alpha-induced insulin resistance by phosphorylating IRS1 at multiple serine residues, resulting in accelerated degradation of IRS1. In cells lacking functional TSC1-2 complex, constitutively phosphorylates and inhibits GSK3B. May be involved in cytoskeletal rearrangement through binding to neurabin. Phosphorylates and activates the pyrimidine biosynthesis enzyme CAD, downstream of MTOR. [PubMed: 11500364]
Protein Sequence MRRRRRRDGFYPAPDFRDREAEDMAGVFDIDLDQPEDAGSEDELEEGGQLNESMDHGGVGPYELGMEHCEKFEISETSVNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSEEDVSQFDSKFTRQTPVDSPDDSTLSESANQVFLGFTYVAPSVLESVKEKFSFEPKIRSPRRFIGSPRTPVSPVKFSPGDFWGRGASASTANPQTPVEYPMETSGIEQMDVTMSGEASAPLPIRQPNSGPYKKQAFPMISKRPEHLRMNL
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
11PhosphorylationRRRRDGFYPAPDFRD
CCCCCCCCCCCCCCC
12.1927642862
32UbiquitinationAGVFDIDLDQPEDAG
CCCEECCCCCCCCCC
7.2329967540
40PhosphorylationDQPEDAGSEDELEEG
CCCCCCCCHHHHHHC
43.5327251275
46UbiquitinationGSEDELEEGGQLNES
CCHHHHHHCCCCCCC
79.74-
46UbiquitinationGSEDELEEGGQLNES
CCHHHHHHCCCCCCC
79.7429967540
51UbiquitinationLEEGGQLNESMDHGG
HHHCCCCCCCCCCCC
31.2629967540
51UbiquitinationLEEGGQLNESMDHGG
HHHCCCCCCCCCCCC
31.26-
53PhosphorylationEGGQLNESMDHGGVG
HCCCCCCCCCCCCCC
28.5612023960
62UbiquitinationDHGGVGPYELGMEHC
CCCCCCHHHHCHHHH
20.1829967540
65UbiquitinationGVGPYELGMEHCEKF
CCCHHHHCHHHHCEE
13.9029967540
75PhosphorylationHCEKFEISETSVNRG
HHCEEECCCCCCCCC
27.8528555341
76UbiquitinationCEKFEISETSVNRGP
HCEEECCCCCCCCCC
51.2529967540
81UbiquitinationISETSVNRGPEKIRP
CCCCCCCCCCHHHCH
60.9429967540
82UbiquitinationSETSVNRGPEKIRPE
CCCCCCCCCHHHCHH
29.5224816145
85UbiquitinationSVNRGPEKIRPECFE
CCCCCCHHHCHHHHH
47.3429967540
95UbiquitinationPECFELLRVLGKGGY
HHHHHHHHHHCCCCC
33.9529967540
99UbiquitinationELLRVLGKGGYGKVF
HHHHHHCCCCCCCEE
45.0329967540
104UbiquitinationLGKGGYGKVFQVRKV
HCCCCCCCEEEEEEE
31.2429967540
112UbiquitinationVFQVRKVTGANTGKI
EEEEEEECCCCCCHH
33.3424816145
118UbiquitinationVTGANTGKIFAMKVL
ECCCCCCHHHHHHHH
32.3929967540
135UbiquitinationAMIVRNAKDTAHTKA
HHHHHCCCHHHCCHH
60.1924816145
137PhosphorylationIVRNAKDTAHTKAER
HHHCCCHHHCCHHHH
21.4522210691
235PhosphorylationHQGHVKLTDFGLCKE
CCCCEEECCCCCCCC
24.4626074081
243PhosphorylationDFGLCKESIHDGTVT
CCCCCCCCCCCCCCE
15.6622322096
248PhosphorylationKESIHDGTVTHTFCG
CCCCCCCCCEEEECC
28.4322322096
250PhosphorylationSIHDGTVTHTFCGTI
CCCCCCCEEEECCEE
18.2922322096
251AcetylationIHDGTVTHTFCGTIE
CCCCCCEEEECCEEH
16.77-
251AcetylationIHDGTVTHTFCGTIE
CCCCCCEEEECCEEH
16.7719608861
252PhosphorylationHDGTVTHTFCGTIEY
CCCCCEEEECCEEHH
15.9722322096
256PhosphorylationVTHTFCGTIEYMAPE
CEEEECCEEHHHCHH
16.3022322096
278PhosphorylationNRAVDWWSLGALMYD
CCCCCHHHHHHHHHH
16.81-
281AcetylationVDWWSLGALMYDMLT
CCHHHHHHHHHHHHH
8.4119608861
304AcetylationNRKKTIDKILKCKLN
CHHHHHHHHHHCCCC
46.1923749302
304MalonylationNRKKTIDKILKCKLN
CHHHHHHHHHHCCCC
46.1926320211
311UbiquitinationKILKCKLNLPPYLTQ
HHHHCCCCCCHHCCH
35.6829967540
317UbiquitinationLNLPPYLTQEARDLL
CCCCHHCCHHHHHHH
20.6529967540
341UbiquitinationSRLGAGPGDAGEVQA
HHCCCCCCCHHHHCC
36.1629967540
347UbiquitinationPGDAGEVQAHPFFRH
CCCHHHHCCCHHHCC
29.6529967540
355PhosphorylationAHPFFRHINWEELLA
CCHHHCCCCHHHHHH
5.8233259812
358PhosphorylationFFRHINWEELLARKV
HHCCCCHHHHHHHHC
33.9932645325
363PhosphorylationNWEELLARKVEPPFK
CHHHHHHHHCCCCCH
43.4532142685
364PhosphorylationWEELLARKVEPPFKP
HHHHHHHHCCCCCHH
45.3933259812
364UbiquitinationWEELLARKVEPPFKP
HHHHHHHHCCCCCHH
45.3929967540
367PhosphorylationLLARKVEPPFKPLLQ
HHHHHCCCCCHHHCC
42.4932645325
370PhosphorylationRKVEPPFKPLLQSEE
HHCCCCCHHHCCCHH
40.3033259812
370UbiquitinationRKVEPPFKPLLQSEE
HHCCCCCHHHCCCHH
40.3029967540
372PhosphorylationVEPPFKPLLQSEEDV
CCCCCHHHCCCHHHH
7.5732142685
372UbiquitinationVEPPFKPLLQSEEDV
CCCCCHHHCCCHHHH
7.5729967540
373PhosphorylationEPPFKPLLQSEEDVS
CCCCHHHCCCHHHHH
7.7532645325
378PhosphorylationPLLQSEEDVSQFDSK
HHCCCHHHHHHCCHH
41.1232142685
380PhosphorylationLQSEEDVSQFDSKFT
CCCHHHHHHCCHHHC
37.1328555341
387PhosphorylationSQFDSKFTRQTPVDS
HHCCHHHCCCCCCCC
26.1320068231
390PhosphorylationDSKFTRQTPVDSPDD
CHHHCCCCCCCCCCC
23.2227362937
391PhosphorylationSKFTRQTPVDSPDDS
HHHCCCCCCCCCCCC
21.4133259812
394PhosphorylationTRQTPVDSPDDSTLS
CCCCCCCCCCCCCCC
30.3820459645
397UbiquitinationTPVDSPDDSTLSESA
CCCCCCCCCCCCHHH
47.08-
398PhosphorylationPVDSPDDSTLSESAN
CCCCCCCCCCCHHHH
38.3320068231
399PhosphorylationVDSPDDSTLSESANQ
CCCCCCCCCCHHHHH
41.1020068231
401PhosphorylationSPDDSTLSESANQVF
CCCCCCCCHHHHHHE
29.5920068231
402UbiquitinationPDDSTLSESANQVFL
CCCCCCCHHHHHHEE
57.9129967540
403PhosphorylationDDSTLSESANQVFLG
CCCCCCHHHHHHEEE
29.1912023960
408PhosphorylationSESANQVFLGFTYVA
CHHHHHHEEEEEEEC
3.8833259812
411PhosphorylationANQVFLGFTYVAPSV
HHHHEEEEEEECHHH
4.9132645325
412PhosphorylationNQVFLGFTYVAPSVL
HHHEEEEEEECHHHH
18.4519934253
413PhosphorylationQVFLGFTYVAPSVLE
HHEEEEEEECHHHHH
7.7320068231
416PhosphorylationLGFTYVAPSVLESVK
EEEEEECHHHHHHHH
18.2232142685
417PhosphorylationGFTYVAPSVLESVKE
EEEEECHHHHHHHHH
29.6020068231
421PhosphorylationVAPSVLESVKEKFSF
ECHHHHHHHHHHCCC
34.0433259812
424PhosphorylationSVLESVKEKFSFEPK
HHHHHHHHHCCCCCC
58.1232645325
425UbiquitinationVLESVKEKFSFEPKI
HHHHHHHHCCCCCCC
40.3629967540
427PhosphorylationESVKEKFSFEPKIRS
HHHHHHCCCCCCCCC
39.5023401153
429PhosphorylationVKEKFSFEPKIRSPR
HHHHCCCCCCCCCCC
44.4832142685
434PhosphorylationSFEPKIRSPRRFIGS
CCCCCCCCCCCCCCC
26.6511914378
441PhosphorylationSPRRFIGSPRTPVSP
CCCCCCCCCCCCCCC
13.3422322096
441 (in isoform 4)Phosphorylation-13.3422210691
444PhosphorylationRFIGSPRTPVSPVKF
CCCCCCCCCCCCCCC
31.2722322096
447PhosphorylationGSPRTPVSPVKFSPG
CCCCCCCCCCCCCCC
25.7722322096
447 (in isoform 4)Phosphorylation-25.7722210691
448 (in isoform 4)Phosphorylation-33.2922210691
450UbiquitinationRTPVSPVKFSPGDFW
CCCCCCCCCCCCCCC
43.43-
452PhosphorylationPVSPVKFSPGDFWGR
CCCCCCCCCCCCCCC
23.4322322096
462PhosphorylationDFWGRGASASTANPQ
CCCCCCCCCCCCCCC
26.10-
470PhosphorylationASTANPQTPVEYPME
CCCCCCCCCCCCCCC
30.4722817900
487PhosphorylationGIEQMDVTMSGEASA
CCCEEEEEECCEECC
11.0129759185
503PhosphorylationLPIRQPNSGPYKKQA
CCCCCCCCCCCCCCC
48.0728674419
506PhosphorylationRQPNSGPYKKQAFPM
CCCCCCCCCCCCCCC
34.0528985074
516AcetylationQAFPMISKRPEHLRM
CCCCCCCCCHHHHCC
62.1320599721
522MethylationSKRPEHLRMNL----
CCCHHHHCCCC----
17.53115486225

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
53SPhosphorylationKinaseNEK6Q9HC98
PSP
252TPhosphorylationKinasePIK3CAP42336
PSP
252TPhosphorylationKinasePDK1O15530
PSP
252TPhosphorylationKinasePDK1Q15118
GPS
390TPhosphorylationKinaseMTORP42345
PhosphoELM
394SPhosphorylationKinaseCDK1P06493
PSP
394SPhosphorylationKinasePDK1O15530
PSP
394SPhosphorylationKinaseMTORQ9JLN9
PSP
394SPhosphorylationKinaseMTORP42345
PSP
403SPhosphorylationKinaseNEK6Q9HC98
PSP
412TPhosphorylationKinaseP70-SUBFAMILY-GPS
412TPhosphorylationKinasePIK3CAP42336
PSP
412TPhosphorylationKinasePDPK1O15530
PhosphoELM
412TPhosphorylationKinasePDK1Q15118
GPS
412TPhosphorylationKinaseNEK7Q8TDX7
Uniprot
412TPhosphorylationKinaseNEK6Q9HC98
Uniprot
412TPhosphorylationKinaseMTORP42345
Uniprot
412TPhosphorylationKinaseRPS6KB1P23443
GPS
427SPhosphorylationKinasePDK1Q15118
GPS
427SPhosphorylationKinasePDPK1O15530
PhosphoELM
434SPhosphorylationKinaseMAPK8Q91Y86
GPS
434SPhosphorylationKinaseMAPK3Q63844
GPS
434SPhosphorylationKinaseERK2P63085
PSP
434SPhosphorylationKinaseMAPK1P28482
GPS
434SPhosphorylationKinaseMAPK9Q9WTU6
GPS
434SPhosphorylationKinaseMTORP42345
PSP
434SPhosphorylationKinaseCDK1P06493
PSP
444TPhosphorylationKinaseTBK1Q9UHD2
PSP
444TPhosphorylationKinaseMAPK3Q63844
GPS
444TPhosphorylationKinaseMAPK1P28482
GPS
444TPhosphorylationKinaseCDK1P06493
PhosphoELM
447SPhosphorylationKinaseCDK1P06493
PSP
447SPhosphorylationKinaseTBK1Q9UHD2
PSP
447SPhosphorylationKinaseMAPK1P28482
GPS
447SPhosphorylationKinaseMAPK3Q63844
GPS
447SPhosphorylationKinaseMTORP42345
PhosphoELM
-KUbiquitinationE3 ubiquitin ligaseRBX1P62877
PMID:18279656

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
252TPhosphorylation

9445476
412TPhosphorylation

9445476
412TPhosphorylation

9445476

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of KS6B1_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
AKT1_HUMANAKT1physical
15149849
CSK2B_HUMANCSNK2Bphysical
16895915
MTOR_HUMANMTORphysical
15899889
MTOR_HUMANMTORphysical
15905173
MTOR_HUMANMTORphysical
12150926
2ABA_HUMANPPP2R2Aphysical
10200280
TERT_HUMANTERTphysical
15843522
XPO1_HUMANXPO1physical
16895915
EIF3B_HUMANEIF3Bphysical
16286006
EIF3F_HUMANEIF3Fphysical
16286006
EF2K_HUMANEEF2Kphysical
11500364
RPTOR_HUMANRPTORphysical
12150926
RPTOR_HUMANRPTORphysical
12604610
PDIP3_HUMANPOLDIP3physical
15341740
XPO1_MOUSEXpo1physical
16895915
RBX1_HUMANRBX1physical
18279656
MDM2_HUMANMDM2physical
20657550
EP300_HUMANEP300physical
19961954
KAT2B_HUMANKAT2Bphysical
19961954
DPPA4_HUMANDPPA4physical
21900206
TETN_HUMANCLEC3Bphysical
21900206
MAD1_HUMANMXD1physical
18451027
EIF3H_HUMANEIF3Hphysical
16286006
RS6_HUMANRPS6physical
21460630
RS6_HUMANRPS6physical
17693255
RPTOR_HUMANRPTORphysical
16837165
PLD2_HUMANPLD2physical
16837165
IRS1_HUMANIRS1physical
23045529
A4_HUMANAPPphysical
21832049
TAU_HUMANMAPTphysical
17512525
RMP_HUMANURI1physical
21397856
TRIB2_HUMANTRIB2physical
24089522
MK08_HUMANMAPK8physical
23816567
RHEB_HUMANRHEBphysical
18550814
MTOR_HUMANMTORphysical
15760907
NR1I2_HUMANNR1I2physical
19171678
EIF3B_HUMANEIF3Bphysical
24396066
EIF3F_HUMANEIF3Fphysical
24396066
KS6B1_HUMANRPS6KB1physical
24396066
TRAF4_HUMANTRAF4physical
25738361
DPTOR_HUMANDEPTORphysical
22017876
PI42A_HUMANPIP4K2Aphysical
12747804
RIR2_HUMANRRM2genetic
28319113
VHL_HUMANVHLgenetic
28319113
IRS1_HUMANIRS1physical
18498745

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of KS6B1_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-304, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-441; THR-444 ANDSER-447, AND MASS SPECTROMETRY.
"Regulation and localization of ribosomal protein S6 kinase 1isoforms.";
Kim D., Akcakanat A., Singh G., Sharma C., Meric-Bernstam F.;
Growth Factors 27:12-21(2009).
Cited for: FUNCTION, ALTERNATIVE SPLICING, PHOSPHORYLATION AT SER-394; THR-412;THR-444 AND SER-447, AND SUBCELLULAR LOCATION.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-441; THR-444 ANDSER-447, AND MASS SPECTROMETRY.
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization.";
Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
Nat. Biotechnol. 24:1285-1292(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-447, AND MASSSPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-441; THR-444 ANDSER-447, AND MASS SPECTROMETRY.
"Structural basis of human p70 ribosomal S6 kinase-1 regulation byactivation loop phosphorylation.";
Sunami T., Byrne N., Diehl R.E., Funabashi K., Hall D.L., Ikuta M.,Patel S.B., Shipman J.M., Smith R.F., Takahashi I., Zugay-Murphy J.,Iwasawa Y., Lumb K.J., Munshi S.K., Sharma S.;
J. Biol. Chem. 285:4587-4594(2010).
Cited for: X-RAY CRYSTALLOGRAPHY (2.35 ANGSTROMS) OF 75-399, AND PHOSPHORYLATIONAT THR-252.
"Phosphorylation and activation of p70s6k by PDK1.";
Pullen N., Dennis P.B., Andjelkovic M., Dufner A., Kozma S.C.,Hemmings B.A., Thomas G.;
Science 279:707-710(1998).
Cited for: ENZYME REGULATION, PHOSPHORYLATION AT THR-252, AND MUTAGENESIS OFTHR-412; SER-434; SER-441; THR-444 AND SER-447.

TOP